Maravai LifeSciences Holdings Inc (MRVI)

40.58 -1.57  -3.72% NASDAQ Dec 6, 15:03 USD

Maravai LifeSciences Holdings Cash from Investing (Quarterly):

-4.202M for June 30, 2021
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Investing (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (Quarterly) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2021 -4.202M
March 31, 2021 -3.032M
Dec. 31, 2020 -8.849M
   
Sept. 30, 2020 -10.09M
June 30, 2020 -3.059M
March 31, 2020 28.07M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Benchmarks

Arrowhead Pharmaceuticals Inc -118.24M
Cassava Sciences Inc -22.04M
Agios Pharmaceuticals Inc -232.73M

Cash from Investing (Quarterly) Range, Past 5 Years

Minimum -10.09M Sep 2020
Maximum 28.07M Mar 2020
Average -0.1943M

News

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.